По вашему запросу найдено документов: 103

Страница 5 из 11

ROLE OF ALLELIC GENES OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS IN THE RISK OF PEPTIC ULCER DISEASE DEVELOPMENT
Shaymardanova, E.Kh., Nurgalieva, A.Kh., Khidiyatova, I.M., Gabbasova, L.V., Kuramshina, O.A., Kryukova, A.Ya., Sagitov, R.B., Munasipov, F.R., Khusnutdinova, E.Kh. (2016)
(rs2276109) and their tissue inhibitors TIMP2 (rs8179090) and TIMP3 (rs9619311) was carried out in 353
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Lomakin, NV, Bakirov, BA, Protsenko, DN, Mazurov, VI, Musaev, GH, Moiseeva, OM, Pasechnik, ES, Popov, VV, Smolyarchuk, EA, Gordeev, IG, Gilyarov, MY, Fomina, DS, Seleznev, AI, Linkova, YN, Dokukina, EA, Eremeeva, AV, Pukhtinskaia, PS, Morozova, MA, Zinkina-Orikhan, AV, Lutckii, AA (2021)
trial was to evaluate the efficacy and safety of IL-6 receptor inhibitor levilimab (LVL) in subjects
ПРИМЕНЕНИЕ МИКРОРИБОНУКЛЕИНОВЫХ КИСЛОТ В ТЕРАПИИ ИШЕМИЧЕСКОГО ИНСУЛЬТА
APPLICATION OF MICRORNA IN THE THERAPY OF ISCHEMIC STROKE
ГАРЕЕВ, И.Ф., НОВИКОВА, Л.Б., БЕЙЛЕРЛИ, О.А., Gareev I.F., Novikova L.B., Beylerli O.A. (2019)
INHIBITORS
Заболевания спектра оптиконевромиелита (ЗСОНМ) – диагностические критерии и подходы к терапии
Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD)
Simaniv, T.O., Bakhtiyarova, K.Z., Belova, A.N., Goncharova, Z.A., Sivertseva, S.A., Spirin, N.N., Totolyan, N.A., Trushnikova, T.N., Turova, E.L., Khaibullin, T.I., Sherman, M.A., Симанив, Т.О., Бахтиярова, К.З., Белова, А.Н., Гончарова, З.А., Сиверцева, С.А., Спирин, Н.Н., Тотолян, Н.А., Трушникова, Т.Н., Турова, Е.Л., Хайбуллин, Т.И., Шерман, М.А., Бойко, А.Н. (2023)
Complement C5 inhibitors
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine
Bernhard, Ohnewein, Zornitsa, Shomanova, Vera, Paar, Albert, Topf, Peter, Jirak, Lukas, Fiedler, Christina, Granitz, Vincent, Van Almsick, Dilvin, Semo, Naufal, Zagidullin, Anna-Maria, Dieplinger, Juergen, Sindermann, Holger, Reinecke, Uta, C Hoppe, Rudin, Pistulli, Lukas, J Motloch (2023)
. Angiotensin-Receptor-Neprilysin-Inhibitors (ARNIs) are an established HFrEF therapy which increases
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
Alexeeva, E, Horneff, G., Dvoryakovskaya, T., Denisova, R., Nikishina, I., Zholobova, E., Malievskiy, V., Santalova, G., Stadler, E., Balykova, L., Spivakovskiy, Y., Kriulin, I., Alshevskaya, A., Moskalev, A. (2021)
TNF inhibitor
Antibacterial activity of noscapine analogs
Ivanenkov, Y.A., Yu. Filyaeva, K., Matniyazov, , R.T., Baymiev, A.K., Baymiev, A.K., Vladimirova, A.A., Yamidanov, R.S., Mavzyutov, A.R., Zileeva, Z.R., Zainullina, L.F., Vakhitova, J.V., Marina, V.I., Terentiev, V.A., Osterman, I.A., Kartsev, V.G., Bezrukov, D.S., Dontsova, O.A. (2021)
Translation inhibitors
Клинический случай лечения метастатического люминального рака молочной железы
Clinical case of the treatment of metastatic luminal breast cancer
Nasretdinov, A.F., Sultanbaev, A.V., Menshikov, K.V., Musin, S.I., Sultanbaeva, N.I., Izmailov, A.A., Ayupov, R.T., Насретдинов, А. Ф., Султанбаев, А. В., Меньшиков, К. В., Мусин, Ш. И., Султанбаева, Н. И., Измайлов, А. А., Аюпов, Р. Т. (2021)
CDK 4/6 inhibitors
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study
Sultanbaev, A.V., Menshikov, K.V., Musin, Sh.I., Nasretdinov, A.F., Fatikhova, A.A., Izmailov, A.A., Lipatov, O.N., Ayupov, R.T., Sultanbayeva, N.I., Menshikova, I.A., Serebrennikov, G.A., Султанбаев, А.В., Меньшиков, К.В., Мусин, Ш.И., Насретдинов, А.Ф., Фатихова, А.А., Измайлов, А.А., Липатов, О.Н., Аюпов, Р.Т., Султанбаева, Н.И., Меньшикова, И.А., Серебренников, Г.А. (2022)
PARP inhibitors
ХАРАКТЕРИСТИКА СОСТОЯНИЯ МИОКАРДА И ПРОФИБРОТИЧЕСКИХ ФАКТОРОВ ПРИ РАЗВИТИИ ГИПЕРТОНИЧЕСКОГО СЕРДЦА
SPECIFICS OF THE STATE OF MYOCARDIUM AND PROFIBROTIC FACTORS IN THE DEVELOPMENT OF HYPERTENSIVE HEART
Mutalova, E.G., Alfukakha, M.M.M., МУТАЛОВА, Э.Г., Альфукаха, М.М.М. (2021)
Tissue matrix metalloproteinase inhibitor

Страница 5 из 11

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год